Microfabrica is working to develop technology for the production of micro-machines and other micro-scale device. The company's flagship technology, EFAB, is designed to allow micro-devices to be produced from a single, automated system, and enable 3D CAD designs to be transformed into finished micro precision parts and MEMS (MicroElectroMechanical Systems).
Research containing Microfabrica
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Microfabrica in 2 CB Insights research briefs, most recently on Jun 8, 2022.
Expert Collections containing Microfabrica
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Microfabrica is included in 2 Expert Collections, including Semiconductors, Chips, and Advanced Electronics.
Semiconductors, Chips, and Advanced Electronics
Companies in the semiconductors & HPC space, including integrated device manufacturers (IDMs), fabless firms, semiconductor production equipment manufacturers, electronic design automation (EDA), advanced semiconductor material companies, and more
Companies in the advanced manufacturing tech space, including companies focusing on technologies across R&D, mass production, or sustainability
Microfabrica has filed 127 patents.
Latest Microfabrica News
Aug 30, 2021
August 30, 2021 08:15 AM Eastern Daylight Time VAN NUYS, Calif.--( BUSINESS WIRE )-- Microfabrica , the world leader in Advanced Micro-Scale Additive Manufacturing and the wholly owned and independently operated subsidiary of Italian multinational Technoprobe SpA , is debuting its latest generation of Micro-Composite MEMS™ Probes during the 30th annual SWTest 2021 conference and expo . The company is participating in the Technoprobe booth both online and onsite at the San Diego event running August 30 through September 1. Microfabrica is the largest pure-play MEMS Probe fabricator in the industry. It has shipped over 200 million MEMS probes to date, enabling the most aggressive product development roadmaps for both SOC and Memory Test. Founded in 1999, Microfabrica pioneered the development of MEMS Probes for use in wafer-level semiconductor testing and has a long history studded with “firsts” including: First to introduce a multi-material MEMS Probe comprised of a spring and wear-resistant tip First to develop a Micro-Composite MEMS™ Probe combining a spring material, a conductor, and wear-resistant tip First to develop a novel impedance-matched MEMS Probe with dielectric for advanced RF and Kelvin Test “We are eager to share Microfabrica’s latest technology with our partners and customers during SWTest 2021,” said Stefano Felici, chief executive officer of Technoprobe. “Although we completed the merger of the two companies in 2019, SWTest is the first industry event in which we are participating together in the same booth. We expect attendees will be immediately struck by how complementary our technology platforms are. The addition of Microfabrica to the Technoprobe family has expanded our technology palette to address the broadest possible range of applications.” Microfabrica Micro-Composite MEMS Probes are on display at SWTest in the Technoprobe booth, number 215, located in the Rancho Bernardo Inn in San Diego. For those attendees unable to travel, Technoprobe is hosting a virtual booth available 24/7 throughout the live event. Technoprobe and Microfabrica experts are on hand at both booths to interact with attendees in real time. SWTest 2021 content will remain available on-demand through October 2, 2021. Attendees who would like to schedule a meeting with Microfabrica or Technoprobe experts during SWTest 2021 should contact firstname.lastname@example.org . About Microfabrica Microfabrica, Inc. is the leader in high-volume production, micro-scale additive manufacturing. By integrating the flexibility of 3D printing with the precision of advanced semiconductor manufacturing processes, the company designs and builds robust micro-scale solutions that enable new levels of product innovation. Global market leaders rely on Microfabrica’s unique technology to deliver breakthrough products, reduce their time to market, and gain a dramatic competitive edge. Microfabrica is a wholly owned and independently operated subsidiary of Technoprobe SpA. Visit www.microfabrica.com for more information. Contacts
Microfabrica Frequently Asked Questions (FAQ)
When was Microfabrica founded?
Microfabrica was founded in 1999.
Where is Microfabrica's headquarters?
Microfabrica's headquarters is located at 7911 Haskell Avenue, Van Nuys.
What is Microfabrica's latest funding round?
Microfabrica's latest funding round is Acquired.
How much did Microfabrica raise?
Microfabrica raised a total of $62.6M.
Who are the investors of Microfabrica?
Investors of Microfabrica include Technoprobe, Partech Partners, Threshold Ventures, Dynafund Ventures, Chevron Technology Ventures and 12 more.
Who are Microfabrica's competitors?
Competitors of Microfabrica include Noraker, REGENESIS BIOMEDICAL, Expanding Orthopedics, Micell Technologies, BioMedical Enterprises and 7 more.
Compare Microfabrica to Competitors
Design, manufacturing and marketing of long term implantable medical devices dedicated to bone reconstruction for applications in orthopedic, spinal, dental and skull-maxillo-facial surgeries.The company's main aim is to conceive bioresorbable implants helping surgeons to improve patients' welfare.
Developing, manufacturing, selling and exporting transcutaneousndevices which will put physiologically active substances intonsubcutaneous tissue applying the theory of electrophoresis. Developing, manufacturing, selling, exporting and importing cosmetic devices, health enhancement devices and medical devices. nnDeveloping, manufacturing, selling, exporting and importing cosmetics. All businesses that are incidental or related to the businesses stated nin the preceding items.
Autocam Medical manufactures high-precision components, instruments, implants and handpieces for a variety of medical applications. Some of the company's products include implants, instruments, handpieces, and components.
Regenesis is engaged in the development, manufacturing, and sale of biomedical devices that promote healing and skin wound closure more quickly and cost-effectively than existing standards of wound treatment. The company's devices are based on its Cell Proliferation Induction (CPI) technology, in which electromagnetic signals trigger the repair and regeneration of soft tissue cells.
Endologix is a company focused on the development and manufacturing of minimally invasive treatments for aortic disorders, operating within the medical devices industry. The company's main offerings include a variety of endovascular stent grafts, which are used for the treatment of abdominal aortic aneurysms (AAA), a condition characterized by a weakening of the wall of the aorta that can lead to a balloon-like enlargement. Endologix primarily serves the healthcare sector, particularly in areas related to vascular disease and aortic disorders. It was founded in 1992 and is based in Irvine, California.
Doctors Research Group focuses on producing and marketing medical products. Currently, they are focusing on the development of a new type of bone cement or bone glue called Kryptonite.